PRESS RELEASE published on 10/30/2025 at 09:00, 5 months 8 days ago Press Release Publication Half-Year Financial Report 2025 Valerio Therapeutics S.A. announces first-half 2025 financial results, discontinuation of clinical activities, and strategic refocus on preclinical R&D. Strengthened financial structure through shareholder advances and capital increases Financial Results Valerio Therapeutics First-half 2025 Preclinical R&D Shareholder Advances
PRESS RELEASE published on 10/30/2025 at 08:58, 5 months 8 days ago Communiqué de presse Mise à disposition du rapport semestriel 2025 Valerio Therapeutics annonce ses résultats financiers du 1er semestre 2025 et fait le point sur ses activités. Renforcement de la R&D préclinique avec les plateformes V-Body et chimie intégrée Résultats Financiers Valerio Therapeutics R&D Préclinique V-Body Chimie Intégrée
BRIEF published on 03/19/2025 at 15:32, 1 year ago Valerio Therapeutics annonce la composition de son conseil d'administration et leurs fonctions Membres Du Conseil D'administration Valerio Therapeutics Rôles En Entreprise Entreprise Basée À Paris Responsabilités Exécutives
BRIEF published on 03/19/2025 at 15:32, 1 year ago Valerio Therapeutics Announces Board Members and Their Roles Board Members Valerio Therapeutics Corporate Roles Paris-based Company Executive Responsibilities
PRESS RELEASE published on 03/19/2025 at 15:27, 1 year ago Inside Information / Other news releases Valerio Therapeutics announces new board members and their positions in other companies as of March 19, 2025 Board Members Positions Valerio Therapeutics Other Companies March 19 2025
BRIEF published on 03/19/2025 at 12:35, 1 year ago Valerio Therapeutics Board Meeting Decisions Director Changes Shareholder Meeting Share Split Board Resolutions Article Amendments
BRIEF published on 03/19/2025 at 12:35, 1 year ago Décisions du conseil d'administration de Valerio Therapeutics Assemblée Des Actionnaires Fractionnement Des Actions Changements De Directeur Résolutions Du Conseil D'administration Modifications D'articles
PRESS RELEASE published on 03/19/2025 at 12:30, 1 year ago Inside Information / Other news releases Valerio Therapeutics Board of Directors convenes a General Meeting with resolutions on director dismissals, co-optation, share division, bylaws amendment, and formalities powers Board Of Directors General Meeting Resolutions Valerio Therapeutics Share Division
PRESS RELEASE published on 03/19/2025 at 12:30, 1 year ago Informations privilégiées / Autres communiqués Rapport du conseil d'administration de VALERIO THERAPEUTICS pour l'AG mixte des actionnaires du 9 avril 2025 concernant révocations, cooptations, division du nominal des actions et modifications statutaires Cooptation Revocation Valerio Therapeutics AG Mixte Division Du Nominal
BRIEF published on 02/04/2025 at 10:40, 1 year 2 months ago Valerio Therapeutics opte pour un recentrage stratégique Innovation Médicale Stratégie Financière Essais Cliniques Oncologie Valerio Therapeutics
Published on 04/07/2026 at 15:00, 3 hours 50 minutes ago Karbon-X Expands Enterprise Climate Platform Through Strategic Partnership with carbon-connect AG
Published on 04/07/2026 at 14:45, 4 hours 5 minutes ago Predictiv AI Introduces Clinical AI Reasoning Platform, Files Patent for Domain-Specific Clinical AI Methodology
Published on 04/07/2026 at 14:40, 4 hours 10 minutes ago bioEnergy Development Inc. Advances Domestic Activated Carbon Production Worth Up to $30 Million Over 5 Years
Published on 04/07/2026 at 14:30, 4 hours 20 minutes ago Measles Rare Pediatric Disease Drug Designation Application Filed for NV-387, PRV Provides for Strong Business Case, Says NanoViricides
Published on 04/07/2026 at 14:30, 4 hours 20 minutes ago Sekur Private Data Announces Philip Oakley and Kenneth Rogers as Members of Strategic Advisory Board
Published on 04/07/2026 at 17:45, 1 hour 5 minutes ago VAZIVA SA: Mise à jour des modalités de l’émission d’obligations convertibles en actions nouvelles (OCA) de 8 M€ à un taux de 7,0% par an et à maturité de 3 ans
Published on 04/07/2026 at 17:45, 1 hour 5 minutes ago FIGEAC AÉRO: INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 04/07/2026 at 17:40, 1 hour 10 minutes ago VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Published on 04/07/2026 at 16:32, 2 hours 18 minutes ago Andera Partners portfolio company, Tubulis, acquired by Gilead, adding a potentially best-in-class antibody-drug conjugate and a next-generation platform to Gilead’s oncology pipeline.
Published on 04/07/2026 at 16:30, 2 hours 20 minutes ago From Old Channel to New Garden: How Chaoyang’s 'Sakura River' is Dazzling Spring
Published on 04/07/2026 at 18:00, 50 minutes ago LDC : Chiffre d’affaires du 4 ème trimestre 2025-2026. Solide croissance du chiffre d’affaires au 4ème trimestre 2025-2026 et révision à la hausse des objectifs.
Published on 04/07/2026 at 17:57, 52 minutes ago Peugeot Invest publishes its 2025 Universal Registration Document
Published on 04/07/2026 at 17:57, 52 minutes ago Mise à disposition du Document d’enregistrement universel 2025
Published on 04/07/2026 at 17:45, 1 hour 5 minutes ago ENGIE accelerates the deployment of battery storage with nearly 400 MW of new projects in Europe
Published on 04/07/2026 at 17:45, 1 hour 5 minutes ago ENGIE accélère le déploiement du stockage par batteries avec près de 400 MW de nouveaux projets en Europe
